Showing results (1781-1790 of 1,961) with videos related to

Sort By:
Pageof 197
Gut|May 19, 2001
Soluble E-cadherin is a valid prognostic marker in gastric carcinomaA O Chan, S K Lam, K M Chu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2014
Incidence and determinants of 1-month mortality after cancer-directed surgeryB A Mahal, G Inverso, A A Aizer, et al.
JAMA Surgery|June 6, 2019
Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder CancerStephen B Williams, Yong Shan, Mohamed D Ray-Zack, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese populationW M Wong, K F Lam, K C Lai, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 11, 2002
Normal 24-hour ambulatory proximal and distal gastroesophageal reflux parameters in ChineseW H C Hu, N Y H Wong, K C Lai, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux diseaseW M Wong, K C Lai, W M Hui, et al.
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
The American Journal of Medicine|February 4, 2015
Who bears the greatest burden of aggressive treatment of indolent prostate cancer?Brandon A Mahal, Matthew R Cooperberg, Ayal A Aizer, et al.
Urology|January 28, 2015
Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patientsJesse D Sammon, Rana R McKay, Simon P Kim, et al.
Leukemia|August 24, 2011
TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic propertiesK C Goh, V Novotny-Diermayr, S Hart, et al.
Pageof 197